An AIM-listed company that tests infectious and respiratory disease products on volunteers is preparing to move its operations to Canary Wharf, E14.
hVIVO, which infects volunteers with safe doses of virus agents, will move from its clinics in Whitechapel, east London, to a larger facility at the Thameside business district early next year.
The new premises span two floors and comprise laboratories, an outpatient unit, offices and 50 quarantine bedrooms that potentially could expand to accommodate 70 beds in future.
To send feedback, e-mail piers.wehner@eg.co.uk or tweet @PiersWehner or @EGPropertyNews
